secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628908-25-000064
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q1 revenue down 24% to $483.6M; net loss widens to $72.3M
------------------------------------------------------------------------

- Revenue $483.6M vs $639.7M YoY; net loss $72.3M vs $25.2M YoY.
- Adjusted EBITDA $36.9M (7.6% margin) vs $54.1M (8.5% margin) YoY.
- Five new revenue agreements added, including surgical management, oncology, and imaging expansions.
- Performance Suite lives declined to 6,486 from 7,050 YoY; specialty technology lives rose to 77,079.
- Company reiterates full-year 2025 revenue and Adjusted EBITDA outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/0001628908-25-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/evh-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628908-25-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer